Maple Securities USA’s Eastman Chemical EMN Stock Holding History

Maple Securities USA’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-53,605	Closed	-$4.18M	–	421
2013 Q3	$4.18M	Buy	+53,605	New	+$4.13M	0.33%	64

Other funds holding EMN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Maple Securities USA's EMN Position: Q4 2013 in Review

Maple Securities USA sold out of Eastman Chemical (EMN) in Q4 2013, closing a stake of 53,605 shares — an estimated $4.18M sold.

Maple Securities USA first reported a position in EMN in Q3 2013 and held it in 1 quarter. The position peaked at $4.18M in Q3 2013. 533 funds tracked by Wall St. Rank hold EMN as of Q4 2013.

Maple Securities USA reported no remaining Eastman Chemical position as of Q4 2013 after selling out during the quarter.
Maple Securities USA sold 53,605 Eastman Chemical shares in Q4 2013, an estimated $4.18M.
Maple Securities USA first reported a position in Eastman Chemical in Q3 2013 and held it in 1 quarter.
Maple Securities USA's Eastman Chemical position peaked at $4.18M in Q3 2013.
533 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2013.

Based on Maple Securities USA's 13F filing for Q4 2013, filed 5 Feb 2014.